We are serving since 1907  
For product complaints and adverse events, toll-free number 1-866-210-9797

info@alembicusa.com908-393-9604

Media

Alembic Buys UTI-Focused Utility Therapeutics In USD 12 Million Deal
3
Jul
2025

Alembic Pharmaceuticals Inc., a wholly owned subsidiary of Alembic Pharmaceuticals Limited, has acquired a 100 percent stake in Utility Therapeutics Ltd, a pharmaceutical company focused on treatments for urinary tract infections (UTIs).Utility Therapeutics is involved in the development and approval of two brand pharmaceutical products for the treatment of urinary tract infections (UTI). -“Pivya” is an FDA approved product to treat uncomplicated UTIs in the US market. -“MEC” is a product in development for the treatment of complicated UTIs in the US market.

Press Release USFDA Tentative Approval Bimatoprost Ophthalmic Solution, 0.03%
6
Aug
2018

Received USFDA Tentative Approval for Bimatoprost Ophthalmic Solution, 0.03%
More...

Anti Cancer Drug Manufacturing Unit Inauguration by Chief Minister of Gujarat
14
Jul
2017

An Anti Cancer Drug Manufacturing Unit at Panelav, Halol, Near Vadodara was Inaugurated by Chief Minister of Gujarat Mr. Vijay Rupani on 14th Jul 2017
More...

BW article
8
Mar
2017

BW article - India's Most Valuable CEO's
More...

Supplier of the year 2016
24
Oct
2016

ANDA: 'Supplier of the year 2016' by ANDA USA
More...

Forbes Award
9
Nov
2016

FORBES AWARD: Forbes India Awards Mr Pranav Amin and Mr. Shaunak Amin as 'NextGen Entrepreneurs of the Year'
More...